EE200100051A - Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon - Google Patents

Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon

Info

Publication number
EE200100051A
EE200100051A EEP200100051A EEP200100051A EE200100051A EE 200100051 A EE200100051 A EE 200100051A EE P200100051 A EEP200100051 A EE P200100051A EE P200100051 A EEP200100051 A EE P200100051A EE 200100051 A EE200100051 A EE 200100051A
Authority
EE
Estonia
Prior art keywords
norcisapride
stereoisomer
pharmaceutically acceptable
pharmaceutical composition
acceptable salt
Prior art date
Application number
EEP200100051A
Other languages
English (en)
Inventor
R. Mccullough John
P. Jerussi Thomas
Original Assignee
Sepracor Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc. filed Critical Sepracor Inc.
Publication of EE200100051A publication Critical patent/EE200100051A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
EEP200100051A 1998-07-28 1999-07-23 Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon EE200100051A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/123,892 US6147093A (en) 1996-07-19 1998-07-28 Methods for treating gastroesophageal reflux disease
PCT/US1999/016736 WO2000006165A1 (en) 1998-07-28 1999-07-23 Methods and compositions for treating gastro-esophageal reflux disease

Publications (1)

Publication Number Publication Date
EE200100051A true EE200100051A (et) 2002-06-17

Family

ID=22411520

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100051A EE200100051A (et) 1998-07-28 1999-07-23 Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon

Country Status (25)

Country Link
US (4) US6147093A (et)
EP (1) EP1100502A1 (et)
JP (1) JP2002521448A (et)
KR (1) KR20010071047A (et)
CN (1) CN1320036A (et)
AR (1) AR019947A1 (et)
AU (1) AU5126099A (et)
BG (1) BG105218A (et)
BR (1) BR9912581A (et)
CA (1) CA2338465A1 (et)
CO (1) CO5060499A1 (et)
CZ (1) CZ295776B6 (et)
EA (1) EA200100188A1 (et)
EE (1) EE200100051A (et)
HK (1) HK1041226A1 (et)
HR (1) HRP20010075A2 (et)
HU (1) HUP0102979A3 (et)
ID (1) ID28894A (et)
IL (1) IL141047A0 (et)
NO (1) NO20010464L (et)
NZ (1) NZ509671A (et)
PL (1) PL345764A1 (et)
SK (1) SK1202001A3 (et)
TR (1) TR200100921T2 (et)
WO (1) WO2000006165A1 (et)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147093A (en) * 1996-07-19 2000-11-14 Sepracor Inc. Methods for treating gastroesophageal reflux disease
PT1000029E (pt) * 1997-07-11 2004-02-27 Janssen Pharmaceutica Nv (+)-norcisaprida util para perturbacoes mediadas por 5-ht3 e 5-bt4
US6353005B1 (en) * 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
DE10314916A1 (de) 2003-04-01 2004-10-21 Endress + Hauser Flowtec Ag, Reinach Vorrichtung zur Bestimmung und/oder Überwachung des Volumen- und/oder Massenstroms eines Mediums
ATE457309T1 (de) * 2003-12-23 2010-02-15 Serodus As Modulatoren von peripheren 5-ht-rezeptoren
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US7176218B2 (en) 2004-01-07 2007-02-13 Aryx Therapeutics Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US20050160544A1 (en) * 2004-01-26 2005-07-28 Marc Geller Contoured grill brush
BRPI0615691A8 (pt) * 2005-08-31 2017-08-15 Aryx Therapeutics Inc Método para a preparação de 6-((3s,4r)-4-(4-amino-5-cloro-2-metoxibenzamido)-3-metoxipiperidin-1-il) hexanoato de (r)-quinuclidin-3-ila ou sal do mesmo
US20080085915A1 (en) * 2006-06-23 2008-04-10 Cyrus Becker Compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US10570127B1 (en) 2018-11-05 2020-02-25 Renexxion, Llc Material and methods for the treatment of gastro-intestinal disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5137896A (en) * 1981-10-01 1992-08-11 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
CA2139638A1 (en) * 1992-07-07 1994-01-20 Nancy M. Gray Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
JPH08502031A (ja) * 1992-07-07 1996-03-05 セプラコア インコーポレーテッド 胃食道逆流疾患およびその他の障害を治療するために▲（＋）▼シサプリドを使用する方法
AU7397194A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-gastrointestinal motility agent combinations
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
US5739151A (en) * 1996-07-19 1998-04-14 Sepracor Inc. Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
US6147093A (en) * 1996-07-19 2000-11-14 Sepracor Inc. Methods for treating gastroesophageal reflux disease
PT1000029E (pt) * 1997-07-11 2004-02-27 Janssen Pharmaceutica Nv (+)-norcisaprida util para perturbacoes mediadas por 5-ht3 e 5-bt4

Also Published As

Publication number Publication date
EP1100502A1 (en) 2001-05-23
CN1320036A (zh) 2001-10-31
HRP20010075A2 (en) 2002-02-28
US20010020031A1 (en) 2001-09-06
CZ2001348A3 (cs) 2002-01-16
US6242465B1 (en) 2001-06-05
CZ295776B6 (cs) 2005-11-16
SK1202001A3 (en) 2001-08-06
NZ509671A (en) 2003-08-29
CA2338465A1 (en) 2000-02-10
US6147093A (en) 2000-11-14
NO20010464L (no) 2001-03-23
NO20010464D0 (no) 2001-01-26
HK1041226A1 (zh) 2002-07-05
BR9912581A (pt) 2001-05-02
AU5126099A (en) 2000-02-21
EA200100188A1 (ru) 2001-08-27
TR200100921T2 (tr) 2001-10-22
CO5060499A1 (es) 2001-07-30
WO2000006165A1 (en) 2000-02-10
PL345764A1 (en) 2002-01-02
HUP0102979A2 (hu) 2001-12-28
AR019947A1 (es) 2002-03-27
US6632827B2 (en) 2003-10-14
KR20010071047A (ko) 2001-07-28
JP2002521448A (ja) 2002-07-16
ID28894A (id) 2001-07-12
US20040044039A1 (en) 2004-03-04
IL141047A0 (en) 2002-02-10
BG105218A (en) 2001-11-30
HUP0102979A3 (en) 2002-01-28

Similar Documents

Publication Publication Date Title
NL300952I2 (nl) Peramivir en farmaceutisch aanvaardbare zouten daarvan
EE04144B1 (et) Farmatseutiline kompositsioon ja selle kasutamine
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
EE200100022A (et) Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
EE04452B1 (et) Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
ID27415A (id) Komposisi farmaseutik
PT1066027E (pt) Composicao farmaceutica de topiramato
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
NO20005913L (no) Legemiddelsammensetning
ZA985618B (en) Sulfonamide compounds and pharmaceutical use thereof
BRPI9810519B1 (pt) derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
IL202633A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
BR9707501A (pt) Composto composição farmacêutica e uso do composto
ID29262A (id) Komposisi farmasi
IL138725A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
BR9707808A (pt) Composto composição farmacêutica e uso do composto
ID27201A (id) Komposisi farmasi
EE200100051A (et) Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE200100314A (et) Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
ID29294A (id) Komposisi farmasi
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
BR9507768A (pt) Composição farmacêutica